PubMed 8595623

View PubMed Search results

Title: Pharmacology of the high-affinity apamin receptor in rabbit heart.

Authors: J A Schetz, P A Anderson

Journal, date & volume: Cardiovasc. Res., 1995 Nov , 30, 755-62

PubMed link:


Apamin is a potent blocker of calcium-activated small conductance potassium (SK) channels in neurons, liver, skeletal muscle and ileum smooth muscle, but not in cardiac muscle. Cardiac muscle is devoid of SK channels; however, in isolated, single ventricular myocytes apamin is an extremely potent blocker of the L-type calcium current, and the anti-arrhythmic drug quinidine reverses apamin block. OBJECTIVE: To characterize the receptor binding properties and pharmacology of the apamin receptor in heart. METHODS: The binding properties of the apamin receptor were determined by rapid filtration of purified rabbit heart membranes. RESULTS: Monoiodinated apamin binds to a labile, membrane-bound protein in heart membranes at a single, high-affinity site (KD = 8.07 +/- 2.14 pM and Bmax = 686 +/- 167 fmoles/mg protein, significant run test at P = 0.05 for a one site fit). 125I-apamin binding is dose-dependently inhibited by apamin, scyllatoxin, quinidine, amiloride, as well as a variety of di- and trivalent cations that are classical blockers of L-type calcium channels (e.g. Co2+, Cd2+, Mn2+, La3+, Gd3+). The cardiac apamin receptor is also critically dependent upon pH, temperature and KCl, and co-purifies in the same membrane fraction as L-type cardiac Ca2+ channels. CONCLUSIONS: The apamin receptor in rabbit heart P2 membranes has pharmacological and biochemical properties in common with both an SK channel and an L-type Ca2+ channel.